Eyenovia Advances Betaliq Merger Talks, Plans FDA Filing for Optejet Device | EYEN Stock News

Mergers & acquisitions News

Eyenovia (NASDAQ: EYEN) provided key updates on its business developments and Q1 2025 financial results. The company continues negotiations with ...

Related articles